Literature DB >> 18581210

Production of ultrafine sumatriptan succinate particles for pulmonary delivery.

Zong-Yang Yang1, Yuan Le, Ting-Ting Hu, Zhigang Shen, Jian-Feng Chen, Jimmy Yun.   

Abstract

PURPOSE: Drug particle physical properties are critical for the efficiency of a drug delivered to the lung. The purpose of this study was to produce ultrafine sumatriptan succinate particles for inhalation.
METHODS: Sumatriptan succinate particles were produced via reactive precipitation without any surfactants. Several low toxic organic solvents such as acetone, isopropanol, and tetrahydrofuran were investigated as the reaction medium. And the dry powder was obtained via spray drying. FT-IR, HPLC, SEM and XRD were exploited to characterize the physicochemical properties of the ultrafine sumatriptan succinate dry powder. The aerosol performance of the powder was evaluated using an Aeroliser connected to a multi stage liquid impinger operating at 60 l/min.
RESULTS: The mean particle size of the ultrafine sumatriptan succinate particles obtained under optimum conditions was in the range of 630-679 nm and consequently they were in the respirable range. The spray-dried powder whose fine particle fraction was increased up to 50.6 +/- 8.2% showed good aerosol performance whereas the vacuum-dried powder was approximate 18.2 +/- 3.0%.
CONCLUSIONS: Good aerosol performance ultrafine sumatriptan succinate particles could be produced by reactive precipitation without any additives followed by spray drying at the optimum parameters.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18581210     DOI: 10.1007/s11095-008-9586-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  17 in total

1.  In-situ-micronization of disodium cromoglycate for pulmonary delivery.

Authors:  Hartwig Steckel; Norbert Rasenack; Bernd W Müller
Journal:  Eur J Pharm Biopharm       Date:  2003-03       Impact factor: 5.571

Review 2.  Novel alternative methods for the delivery of drugs for the treatment of asthma.

Authors:  Hak Kim Chan; Nora Y K Chew
Journal:  Adv Drug Deliv Rev       Date:  2003-07-18       Impact factor: 15.470

3.  Jet milling--a new technique for microparticle preparation.

Authors:  G Nykamp; U Carstensen; B W Müller
Journal:  Int J Pharm       Date:  2002-08-21       Impact factor: 5.875

Review 4.  Dry powder inhaler formulation.

Authors:  Martin J Telko; Anthony J Hickey
Journal:  Respir Care       Date:  2005-09       Impact factor: 2.258

5.  Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan.

Authors:  Rita J Majithiya; Pradip K Ghosh; Manish L Umrethia; Rayasa S R Murthy
Journal:  AAPS PharmSciTech       Date:  2006-08-04       Impact factor: 3.246

Review 6.  Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.

Authors:  P Tfelt-Hansen; P De Vries; P R Saxena
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

7.  Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan.

Authors:  S S Colman; M I Brod; A Krishnamurthy; C R Rowland; K J Jirgens; B Gomez-Mancilla
Journal:  Clin Ther       Date:  2001-01       Impact factor: 3.393

Review 8.  Migraine headache: options for acute treatment.

Authors:  Frederick R Taylor
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

9.  Preparation of inhalable salbutamol sulphate using reactive high gravity controlled precipitation.

Authors:  Tingting Hu; Herbert Chiou; Hak-Kim Chan; Jian-Feng Chen; Jimmy Yun
Journal:  J Pharm Sci       Date:  2008-02       Impact factor: 3.534

10.  Feasibility of preparing nanodrugs by high-gravity reactive precipitation.

Authors:  Jian-Feng Chen; Min-Yi Zhou; Lei Shao; Yu-Yong Wang; Jimmy Yun; Nora Y K Chew; Hak-Kim Chan
Journal:  Int J Pharm       Date:  2004-01-09       Impact factor: 5.875

View more
  5 in total

1.  Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent.

Authors:  Nashwa El-Gendy; Kristin L Aillon; Cory Berkland
Journal:  Int J Pharm       Date:  2010-03-07       Impact factor: 5.875

2.  Iodinated NanoClusters as an inhaled computed tomography contrast agent for lung visualization.

Authors:  Kristin L Aillon; Nashwa El-Gendy; Connor Dennis; Jeffrey P Norenberg; Jacob McDonald; Cory Berkland
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

3.  Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols.

Authors:  Nashwa El-Gendy; Warangkana Pornputtapitak; Cory Berkland
Journal:  Eur J Pharm Sci       Date:  2011-09-21       Impact factor: 4.384

4.  Preparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using Box-Behnken design.

Authors:  Jifu Hao; Yun Gao; Jing Zhao; Jimei Zhang; Qiankui Li; Zhongxi Zhao; Jiyong Liu
Journal:  AAPS PharmSciTech       Date:  2014-09-11       Impact factor: 3.246

5.  Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration.

Authors:  Nashwa El-Gendy; Cory Berkland
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.